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Using signature-tagged transposon mutagenesis, we isolated 23 Mycobacterium tuberculosis mutants, corre-
sponding to 21 genes or genetic regions, attenuated in their ability to parasitize human macrophages. Mutants
disrupted in the ABC transporter-encoding genes Rv0986 and Rv0987 were further characterized as being
impaired in their ability to bind to host cells.
Parasitism of host macrophages (Ms) by pathogenic myco-
bacteria, including Mycobacterium tuberculosis, the agent of
tuberculosis in humans, is a key feature of mycobacterial vir-
ulence that needs to be further understood (7, 11, 25). M
infection by the bacillus involves adhesion to and phagocytosis-
mediated entry inside the host cell, as well as resistance to
phagosome-lysosome fusion and to free radicals (25). A better
comprehension of the microbial molecular determinants in-
volved in these processes might help not only to better under-
stand the cell biology of mycobacterial infections but also to
design novel targets for new antimycobacterials and possibly
better vaccine candidates. Various approaches have been used
in the past to identify mycobacterial genes involved in macro-
phage infection. These approaches include promoter fusion to
reporter genes in order to identify genes induced intracellu-
larly (6, 31), substractive hybridization techniques (8, 21), and
transcriptome (27) and proteome (12, 16) analyses, as well as
screening of mutant libraries (4, 18, 20, 28). Here we took
advantage of the negative selection technique signature-tagged
transposon mutagenesis (STM) (9) to identify virulence genes
required for M. tuberculosis parasitism of human Ms.
Screening of anM. tuberculosis STM library in human Ms.
Mycobacteria were grown at 37°C in Middlebrook 7H9 broth
(Difco Laboratories, Detroit, MI) supplemented with 10%
oleic acid-albumin-dextrose-catalase (OADC; Difco Laborato-
ries) and 0.05% Tween 80 (Sigma-Aldrich, Corp., St. Louis,
MO). THP-1 (ATCC TIB-202) cells were grown in RPMI 1640
(Gibco, Grand Island, NY) supplemented with 10% fetal bo-
vine serum (Dutscher, Brumath, France). THP-1 monocytes
were differentiated into Ms by incubation with 10 ng of phor-
bol 12-myristate 13-acetate (Sigma)/ml for 48 h. An STM li-
brary of 1,410 members was constructed with M. tuberculosis
MT103 as a parental strain (4) and was used to infect THP-1
Ms for 7 days (input pools). Bacteria were extracted from
infected cells and used in a new 7-day infection round in order
to enrich in attenuated mutants. Transposon-mediated M. tu-
berculosis mutants were cultured in the presence of kanamycin
(20 g/ml; Sigma). To dislocate clumps, bacteria were pas-
saged through a needle and mildly centrifuged before infec-
tion, as described previously (24, 29). Infected cells were lysed
after each infection round, and bacteria were recovered by
plating the material onto selective agar medium. Mutants were
recovered 3 weeks after culture (output pools), and the chro-
mosomal DNA was extracted as described previously (17).
Tags from input and output pools were amplified and hybrid-
ized as described previously (4). From the initial 1,410 mu-
tants, 32 were selected as candidate attenuated clones after
two 7-day infection rounds. Of the 32 candidates, 23 were
firmly confirmed as attenuated after individual infection of
THP-1 Ms and comparison of doubling times with the wild-
type strain over a 7-day period (Table 1). Transposon insertion
sites were identified by ligation-mediated PCR and sequencing
as described previously (19). The identified virulence genes
(Table 1) included genes potentially involved in lipid metabo-
lism and cell wall biosynthesis (papA1, mmpL2, pks6, Rv2958c,
alkB, and drrB), as well as genes involved in intermediary me-
tabolism and metal utilization (bfrB, moaC1, moaX, Rv1817, and
Rv0097), genes of the PE/PPE family (ppe5 and ppe8), and genes
of yet-unknown function (Rv2227, Rv2336, Rv1502 and Rv1503c,
Rv2104c, and Rv2954c and Rv2955c). Interestingly, some of these
genes (mmpL2, drrB, Rv0986, and Rv2336) have been suggested
to play a part in mycobacterial virulence in previous studies based
on various in vivo and in vitro screening approaches (4, 18, 26).
This reinforces the relevance of the STM technology to search for
virulence genes in M. tuberculosis.
Rv0986 and Rv0987 disruption reduces the ability of M.
tuberculosis to bind to host cells. One additional attenuated
mutant carried a transposon insertion immediately after nu-
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cleotide T554 in Rv0986, with the transposon (Tn) kanamycin
resistance gene oriented in the same direction as the Rv0986
gene. Rv0986 has been recently identified as playing a part in
the inhibition of phagosome-lysosome fusion through a screen-
ing approach at the subcellular level (18). It encodes a putative
ATP-binding protein sharing high similarity with the Agrobac-
terium tumefaciens AttE polypeptide and predicted to form an
ABC transporter together with Rv0987 (3). In A. tumefaciens,
an -proteobacterium responsible for crown gall in plants, the
plasmid-borne attE-H genes are thought to encode an ABC
transporter involved in the secretion of a host cell adherence
factor (13, 14). We have recently shown that the Rv0986-8
gene cluster arose through horizontal gene transfer in the
ancestor of M. tuberculosis (22). The individual infection pro-
file of the Rv0986::Tn mutant in THP-1 Ms (Fig. 1A) sug-
gested that this gene might be involved in mycobacterial ad-
herence to host cells. In order to validate this phenotype, cold
binding assays (30) were realized using the Rv0986::Tn mutant.
In addition, a Rv0987::Tn mutant generated independently by
transposon mutagenesis for the purpose of another study (10)
and carrying a Tn insertion immediately after nucleotide C1592
was included in the experiments. Cells were infected in tripli-
cates for 4 h at 4°C in RPMI 1640 at a multiplicity of infection
of one bacterium per cell, extensively washed in phosphate-
buffered saline, lysed, and plated onto agar medium for CFU
scoring. The Rv0986::Tn and Rv0987::Tn mutants were found
to be affected in their ability to bind to THP-1 Ms (Fig. 1B).
Binding of the Rv0986::Tn mutant was reduced by 51.5% 
11.8% (n  4) compared to that of the wild-type strain. This
phenotype could be restored after complementation using
pYUB412-derived cosmids (1) (Fig. 1B). The MTCI229 and
MTCI310 cosmids used in the study carry 38.7- and 20.8-kb
DNA fragments covering the 1077.0- to 1115.7-kb and 1086.5-
to 1107.3-kb regions of the M. tuberculosis chromosome. These
cosmids encompass the Rv0986-8 operon (1101.8 to 1106.3 kb,
genomic coordinates). The binding default of the two mutant
strains was confirmed at 37°C using 2 g of cytochalasin D
FIG. 1. Rv0986-8 plays a key role in M. tuberculosis binding to host
cells. (A) Infection profile of M. tuberculosis wild-type and Rv0986::Tn
strains in THP-1 Ms. (B) Binding capacity of M. tuberculosis wild-type
(WT), Rv0986::Tn, Rv0987::Tn, and MTCI229- and MTCI310-com-
plemented mutant strains to THP-1 Ms. Cells were infected for 4 h
at 4°C. (C) Binding capacity of M. tuberculosis wild-type (WT),
Rv0986::Tn, and Rv0987::Tn strains to THP-1 Ms. Cells were in-
fected for 4 h at 37°C in the presence of cytochalasin D. (D) Binding
capacity of M. tuberculosis wild-type (WT), Rv0986::Tn, and
Rv0987::Tn strains to mouse bone marrow-derived Ms (mBMMs)
and human monocyte-derived Ms (hMDMs). Cells were infected for
4 h at 4°C or at 37°C. (E) Intracellular survival of M. tuberculosis
MT103 wild-type (WT), Rv0986::Tn, and Rv0987::Tn strains in human
MDMs. (F) Binding capacity of M. tuberculosis wild-type (WT),
Rv0986::Tn, erp-deficient, Rv1502::Tn, yrbE4A::Tn, drrB::Tn, moaX::
Tn, ppe5::Tn, ppe8::Tn and bfrB::Tn strains to THP-1 Ms. Cells were
infected for 4 h at 4°C. *, P  0.05; **, P  0.01 (Mann-Whitney test
of median comparison).
TABLE 1. Attenuated M. tuberculosis mutants identified by STM
Mutant Disrupted ORFa Putative function Growthindexb
Other
studiesc
28AD1 mmpL2 Fatty acid transport 0.7 4
38AA2 Rv0097 Possible oxido-reductase 0.7
28AA4 Rv0986 ABC transporter 0.7 18
31AC3 Rv2227 Unknown 0.6
36AB4 Rv1817 Flavoprotein 0.6
36BF6 drrB Phthiocerol dimycocerosate
transport
0.6 26
38AC3 Rv2954c-Rv2955c* Unknown-unknown 0.6
28AA2 yrbE4A Part of mce4 operon 0.5 26
27BB3 bfrB* Iron metabolism
(bacterioferritin)
0.4
31AA2 moaC1 Molybdopterin synthesis 0.4
36AF2 Rv1502 Unknown 0.4
27AC6 alkB Fatty acid metabolism 0.3
28AB3 papA1 Sulfolipid synthesis 0.3
35AA4 ppe5 PE/PPE family 0.3
36AC2 pks6 Polyketide synthase 0.3
36AC3 ppe8 PE/PPE family 0.3
28BG4 Rv2336 Unknown 0.2 18
29BG6 Rv2104c-Rv2105* Unknown-IS6110
transposase
0.2
31AG4 Rv2336 Unknown 0.2
34AG4 Rv2958c* Glycosyltransferase 0.2
36AF4 moaX Molybdopterin synthesis 0.2
38AB3 Rv1502-Rv1503c* Unknown-unknown 0.2
27AA2 ppe5 PE/PPE family 0.2
a ORF, open reading frame. *, A Tn insertion occurred upstream of the
starting site or in between the two genes.
b The growth index was calculated as the doubling time of wild-type M. tuber-
culosis divided by that of the mutant in THP-1 cells over a 7-day period.
c The genes have been previously identified in other genetic screenings in vivo
or in vitro.
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(Sigma)/ml in order to block phagocytosis (Fig. 1C) and was
also observed in human blood monocyte- and murine bone
marrow-derived Ms prepared as described previously (24, 29)
(Fig. 1D), as well as in nonphagocytic cells such as epithelial
cells and fibroblasts (data not shown). Once inside phagocytes,
when grown at 37°C, the mutants were not significantly im-
paired in their ability to replicate compared to the wild-type
strain (Fig. 1E). This result seems at odds with that from
another study (18), in which a Rv0986-deficient mutant was
found to be impaired in its ability to block phagosome-lyso-
some fusion and to replicate inside Ms. This difference be-
tween the two studies might be due to the different contexts in
which the mutants were generated. We used M. tuberculosis
MT103 as the parental strain, whereas Pethe et al. (18) used
CDC1551 to construct their mutant.
Analysis of the secreted products inM. tuberculosis wild-type
and Rv0987::Tn strains. The results above raised the possibility
that the Rv0986-7 transporter might secrete an adherence factor
that allows bacteria binding to macrophages and other cell types.
Analysis of the lipid and sugar contents in the cell envelope, as
well as in the secreted products, revealed no major difference in
the amount and structure of methyl-branched fatty acid-contain-
ing acyltrehaloses, cord factor, phospholipids, phosphatidylinosi-
tolmannosides, phthiocerol dimycocerosates, mycolic acids, glu-
can, arabinomannan, mannan, and lipoarabinomannan between
the Rv0987::Tn mutant and the wild-type strains (data not
shown). This suggests that the Rv0986-7 transporter may carry
an as-yet-unidentified protein, polysaccharide or (glyco)lipid,
which will require further examination.
Another possible explanation is that Rv0986 and Rv0987
disruption might alter the architecture and integrity of the
mycobacterial cell wall, which is likely to affect the adherence
properties of the bacillus. In order to assess how common was
the adhesion defect among the mutants we have isolated, we
have repeated the binding assay using a cohort of these mu-
tants, together with another attenuated mutant inactivated in
the erp gene encoding a cell surface virulence factor (2). As
shown in Fig. 1F, binding of the Rv0986-, erp-, yrbE4A-, and
Rv1502-deficient mutants was found to be significantly altered
compared to that of the wild-type strain, whereas binding of
the other strains tested (deficient in drrB, moaX, ppe5, pe8, and
bfrB) was not. Diminished binding of the erp-deficient strain to
host cells has been observed previously (J.-M. Reyrat, unpub-
lished data). The yrbE4A gene is part of the mce operons that
are involved in host cell entry. Mce1 has been shown to pro-
mote adhesion of latex beads to HeLa cells (5), and Mce4A
(Yrbe4A) has been suggested to have a similar property (15).
Both erp and mce genes encode products located in the cell
envelope of the bacillus. Alteration of the cell envelope archi-
tecture is likely to affect the ability of the strain to bind to cells,
which has also been observed in other mutants of the cell
envelope (23). The reduced ability of the Rv0986- and Rv0987-
deficient mutants to bind to host cells might thus be the con-
sequence of any alteration of the cell envelope architecture in
these strains rather than of the lack of an adherence product
secreted by the operon.
Rv0986 and Rv0987 disruption does not reduce M. tubercu-
losis virulence in vivo. In order to evaluate the phenotype of
the two mutants in vivo, we infected 6- to 8-week-ld female
C57BL/6 mice (Jackson Laboratories, Bar Harbor, Maine) in-
tranasally with 1,000 CFU of the wild type or mutant strains,
and we collected lungs and spleens 1, 21, and 42 days after
inoculation for bacterial load measurement (Fig. 2). Although
statistically significant, the reduction in CFU of the mutants
observed in the lungs of the animals 21 days after infection
probably did not result from a genuine in vivo attenuation but
rather from lower infecting doses (see the bacterial loads at
day 1). This difference was not observed in the spleen at either
time point and was even reversed in the lungs at the later time
point observed (day 42). Histological examination of the lungs
did not reveal any marked differences in inflammation and
granuloma formation between the wild-type and the mutant
strains (data not shown). Since the Rv0986::Tn and Rv0987::
Tn mutants show a cell-binding defect, this result raises the
possibility that reinfection of host cells in vivo might not be
required for sustaining the infection over time, which will re-
quire further investigation.
In conclusion, the present study describes novel M. tubercu-
losis genes involved in M parasitism and demonstrates this
virulence process to be a multifactorial phenomenon. In addi-
tion to its possible role in early phagosome remodeling (18),
the Rv0986-7-encoded ABC transporter is likely to be involved
in host cell binding either through secretion of an as-yet-
unidentified adherence factor or through maintaining the
architecture and integrity of the mycobacterial cell enve-
lope. Future studies will seek to decipher the exact role of
the various virulence factors, including Rv0986 and Rv0987,
identified through this STM-based approach in M. tubercu-
losis pathogenesis.
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